To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The global High Throughput Screening (HTS) Service market size was valued at US$ 288 million in 2023 and is forecast to a readjusted size of USD 559 million by 2030 with a CAGR of 9.9% during review period.
The world's core manufacturers of High Throughput Screening (HTS) Service include Eurofins Discovery, Charles River Laboratories and Axcelead. The top three companies have a market share of about 24 percent. The United States and Canada are the world's largest High Throughput Screening (HTS) Service market with a market share of about 46%, followed by China and Europe with a market share of 19% and 15%, respectively. In terms of product type, Chemical-based HTS Service is the largest segment with approximately 40% market share. In terms of application, Pharmaceutical Industry is the largest downstream segment, accounting for about 80% of the market.
This report is a detailed and comprehensive analysis for global High Throughput Screening (HTS) Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global High Throughput Screening (HTS) Service market size and forecasts, in consumption value ($ Million), 2019-2030
Global High Throughput Screening (HTS) Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global High Throughput Screening (HTS) Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global High Throughput Screening (HTS) Service market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Throughput Screening (HTS) Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global High Throughput Screening (HTS) Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
High Throughput Screening (HTS) Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
High Throughput Screening (HTS) Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Chemical-based HTS Service
Biological-based HTS Service
Cell-based HTS Service
Genetic-based HTS Service
麻豆原创 segment by Application
Pharmaceutical Industry
Universities and Scientific Research Institutions
麻豆原创 segment by players, this report covers
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe High Throughput Screening (HTS) Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of High Throughput Screening (HTS) Service, with revenue, gross margin, and global market share of High Throughput Screening (HTS) Service from 2019 to 2024.
Chapter 3, the High Throughput Screening (HTS) Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and High Throughput Screening (HTS) Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of High Throughput Screening (HTS) Service.
Chapter 13, to describe High Throughput Screening (HTS) Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of High Throughput Screening (HTS) Service by Type
1.3.1 Overview: Global High Throughput Screening (HTS) Service 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global High Throughput Screening (HTS) Service Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Chemical-based HTS Service
1.3.4 Biological-based HTS Service
1.3.5 Cell-based HTS Service
1.3.6 Genetic-based HTS Service
1.4 Global High Throughput Screening (HTS) Service 麻豆原创 by Application
1.4.1 Overview: Global High Throughput Screening (HTS) Service 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical Industry
1.4.3 Universities and Scientific Research Institutions
1.5 Global High Throughput Screening (HTS) Service 麻豆原创 Size & Forecast
1.6 Global High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast by Region
1.6.1 Global High Throughput Screening (HTS) Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global High Throughput Screening (HTS) Service 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America High Throughput Screening (HTS) Service 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe High Throughput Screening (HTS) Service 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific High Throughput Screening (HTS) Service 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America High Throughput Screening (HTS) Service 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa High Throughput Screening (HTS) Service 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Eurofins Discovery
2.1.1 Eurofins Discovery Details
2.1.2 Eurofins Discovery Major Business
2.1.3 Eurofins Discovery High Throughput Screening (HTS) Service Product and Solutions
2.1.4 Eurofins Discovery High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Eurofins Discovery Recent Developments and Future Plans
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories High Throughput Screening (HTS) Service Product and Solutions
2.2.4 Charles River Laboratories High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Charles River Laboratories Recent Developments and Future Plans
2.3 Axcelead
2.3.1 Axcelead Details
2.3.2 Axcelead Major Business
2.3.3 Axcelead High Throughput Screening (HTS) Service Product and Solutions
2.3.4 Axcelead High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Axcelead Recent Developments and Future Plans
2.4 NUVISAN
2.4.1 NUVISAN Details
2.4.2 NUVISAN Major Business
2.4.3 NUVISAN High Throughput Screening (HTS) Service Product and Solutions
2.4.4 NUVISAN High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 NUVISAN Recent Developments and Future Plans
2.5 Axxam S.p.A.
2.5.1 Axxam S.p.A. Details
2.5.2 Axxam S.p.A. Major Business
2.5.3 Axxam S.p.A. High Throughput Screening (HTS) Service Product and Solutions
2.5.4 Axxam S.p.A. High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Axxam S.p.A. Recent Developments and Future Plans
2.6 Evotec
2.6.1 Evotec Details
2.6.2 Evotec Major Business
2.6.3 Evotec High Throughput Screening (HTS) Service Product and Solutions
2.6.4 Evotec High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Evotec Recent Developments and Future Plans
2.7 Selvita
2.7.1 Selvita Details
2.7.2 Selvita Major Business
2.7.3 Selvita High Throughput Screening (HTS) Service Product and Solutions
2.7.4 Selvita High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Selvita Recent Developments and Future Plans
2.8 Azenta Life Sciences
2.8.1 Azenta Life Sciences Details
2.8.2 Azenta Life Sciences Major Business
2.8.3 Azenta Life Sciences High Throughput Screening (HTS) Service Product and Solutions
2.8.4 Azenta Life Sciences High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Azenta Life Sciences Recent Developments and Future Plans
2.9 Bienta (Enamine)
2.9.1 Bienta (Enamine) Details
2.9.2 Bienta (Enamine) Major Business
2.9.3 Bienta (Enamine) High Throughput Screening (HTS) Service Product and Solutions
2.9.4 Bienta (Enamine) High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Bienta (Enamine) Recent Developments and Future Plans
2.10 Cayman Chemical
2.10.1 Cayman Chemical Details
2.10.2 Cayman Chemical Major Business
2.10.3 Cayman Chemical High Throughput Screening (HTS) Service Product and Solutions
2.10.4 Cayman Chemical High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Cayman Chemical Recent Developments and Future Plans
2.11 Creative Biolabs
2.11.1 Creative Biolabs Details
2.11.2 Creative Biolabs Major Business
2.11.3 Creative Biolabs High Throughput Screening (HTS) Service Product and Solutions
2.11.4 Creative Biolabs High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Creative Biolabs Recent Developments and Future Plans
2.12 Creative Bioarray
2.12.1 Creative Bioarray Details
2.12.2 Creative Bioarray Major Business
2.12.3 Creative Bioarray High Throughput Screening (HTS) Service Product and Solutions
2.12.4 Creative Bioarray High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Creative Bioarray Recent Developments and Future Plans
2.13 BOC Sciences
2.13.1 BOC Sciences Details
2.13.2 BOC Sciences Major Business
2.13.3 BOC Sciences High Throughput Screening (HTS) Service Product and Solutions
2.13.4 BOC Sciences High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 BOC Sciences Recent Developments and Future Plans
2.14 MEDICILON
2.14.1 MEDICILON Details
2.14.2 MEDICILON Major Business
2.14.3 MEDICILON High Throughput Screening (HTS) Service Product and Solutions
2.14.4 MEDICILON High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 MEDICILON Recent Developments and Future Plans
2.15 Domainex
2.15.1 Domainex Details
2.15.2 Domainex Major Business
2.15.3 Domainex High Throughput Screening (HTS) Service Product and Solutions
2.15.4 Domainex High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Domainex Recent Developments and Future Plans
2.16 Creative Diagnostics
2.16.1 Creative Diagnostics Details
2.16.2 Creative Diagnostics Major Business
2.16.3 Creative Diagnostics High Throughput Screening (HTS) Service Product and Solutions
2.16.4 Creative Diagnostics High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Creative Diagnostics Recent Developments and Future Plans
2.17 Multispan
2.17.1 Multispan Details
2.17.2 Multispan Major Business
2.17.3 Multispan High Throughput Screening (HTS) Service Product and Solutions
2.17.4 Multispan High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Multispan Recent Developments and Future Plans
2.18 AntalGenics
2.18.1 AntalGenics Details
2.18.2 AntalGenics Major Business
2.18.3 AntalGenics High Throughput Screening (HTS) Service Product and Solutions
2.18.4 AntalGenics High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 AntalGenics Recent Developments and Future Plans
2.19 Creative Biostructure
2.19.1 Creative Biostructure Details
2.19.2 Creative Biostructure Major Business
2.19.3 Creative Biostructure High Throughput Screening (HTS) Service Product and Solutions
2.19.4 Creative Biostructure High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 Creative Biostructure Recent Developments and Future Plans
2.20 BPS Bioscience
2.20.1 BPS Bioscience Details
2.20.2 BPS Bioscience Major Business
2.20.3 BPS Bioscience High Throughput Screening (HTS) Service Product and Solutions
2.20.4 BPS Bioscience High Throughput Screening (HTS) Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 BPS Bioscience Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global High Throughput Screening (HTS) Service Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of High Throughput Screening (HTS) Service by Company Revenue
3.2.2 Top 3 High Throughput Screening (HTS) Service Players 麻豆原创 Share in 2023
3.2.3 Top 6 High Throughput Screening (HTS) Service Players 麻豆原创 Share in 2023
3.3 High Throughput Screening (HTS) Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 High Throughput Screening (HTS) Service 麻豆原创: Region Footprint
3.3.2 High Throughput Screening (HTS) Service 麻豆原创: Company Product Type Footprint
3.3.3 High Throughput Screening (HTS) Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global High Throughput Screening (HTS) Service Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global High Throughput Screening (HTS) Service 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global High Throughput Screening (HTS) Service Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global High Throughput Screening (HTS) Service 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America High Throughput Screening (HTS) Service Consumption Value by Type (2019-2030)
6.2 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Application (2019-2030)
6.3 North America High Throughput Screening (HTS) Service 麻豆原创 Size by Country
6.3.1 North America High Throughput Screening (HTS) Service Consumption Value by Country (2019-2030)
6.3.2 United States High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe High Throughput Screening (HTS) Service Consumption Value by Type (2019-2030)
7.2 Europe High Throughput Screening (HTS) Service Consumption Value by Application (2019-2030)
7.3 Europe High Throughput Screening (HTS) Service 麻豆原创 Size by Country
7.3.1 Europe High Throughput Screening (HTS) Service Consumption Value by Country (2019-2030)
7.3.2 Germany High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific High Throughput Screening (HTS) Service Consumption Value by Type (2019-2030)
8.2 Asia-Pacific High Throughput Screening (HTS) Service Consumption Value by Application (2019-2030)
8.3 Asia-Pacific High Throughput Screening (HTS) Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific High Throughput Screening (HTS) Service Consumption Value by Region (2019-2030)
8.3.2 China High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America High Throughput Screening (HTS) Service Consumption Value by Type (2019-2030)
9.2 South America High Throughput Screening (HTS) Service Consumption Value by Application (2019-2030)
9.3 South America High Throughput Screening (HTS) Service 麻豆原创 Size by Country
9.3.1 South America High Throughput Screening (HTS) Service Consumption Value by Country (2019-2030)
9.3.2 Brazil High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa High Throughput Screening (HTS) Service Consumption Value by Type (2019-2030)
10.2 Middle East & Africa High Throughput Screening (HTS) Service Consumption Value by Application (2019-2030)
10.3 Middle East & Africa High Throughput Screening (HTS) Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa High Throughput Screening (HTS) Service Consumption Value by Country (2019-2030)
10.3.2 Turkey High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE High Throughput Screening (HTS) Service 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 High Throughput Screening (HTS) Service 麻豆原创 Drivers
11.2 High Throughput Screening (HTS) Service 麻豆原创 Restraints
11.3 High Throughput Screening (HTS) Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 High Throughput Screening (HTS) Service Industry Chain
12.2 High Throughput Screening (HTS) Service Upstream Analysis
12.3 High Throughput Screening (HTS) Service Midstream Analysis
12.4 High Throughput Screening (HTS) Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Eurofins Discovery
Charles River Laboratories
Axcelead
NUVISAN
Axxam S.p.A.
Evotec
Selvita
Azenta Life Sciences
Bienta (Enamine)
Cayman Chemical
Creative Biolabs
Creative Bioarray
BOC Sciences
MEDICILON
Domainex
Creative Diagnostics
Multispan
AntalGenics
Creative Biostructure
BPS Bioscience
听
听
*If Applicable.